Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
DUBAI, United Arab Emirates, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) has announced the completion of its core lending and borrowing smart contracts, marking a significant step...
Read More -
COSTCO BUSINESS CENTRE IS NOW OPEN IN EAST GWILLIMBURY - 240 JOBS CREATED, THOUSANDS OF UNIQUE ITEMS TAILORED TO BUSINESS NEEDS
Read More
-
DUBAI, United Arab Emirates, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) has announced the completion of its core lending and borrowing smart contracts, marking a significant step...
-
MIAMI BEACH, Fla., Dec. 06, 2025 (GLOBE NEWSWIRE) -- The USA is about to pulse with patriotic, Pro-Trump anthems as Sticker Mule CEO and Republican firebrand Anthony Constantino will be dropping his...
-
First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative neoplasms PRT12396 has completed GLP toxicology studies and is on...
-
Lisaftoclax monotherapy demonstrated significant and durable clinical efficacy and a manageable safety profile in patients with heavily pretreated BTK-refractory R/R CLL/SLL, underscoring its utility...
-
Lakewood Ranch, Dec. 06, 2025 (GLOBE NEWSWIRE) -- JCBC Publishing, LLC, a distinguished name in the literary world, proudly announces the upcoming release of 'That Kind of Girl,' the debut novel by...
-
Austin, Dec. 06, 2025 (GLOBE NEWSWIRE) -- The Labor Management System Market size was valued at USD 3.69 Billion in 2025E and is expected to reach USD 7.35 Billion by 2033 and grow at a CAGR of...
-
The case alleges Perrigo hid deep underinvestment and manufacturing issues in its infant formula unit, overstating needed costs and financial results.
-
Austin, Dec. 06, 2025 (GLOBE NEWSWIRE) -- The System Infrastructure Software Market was valued at USD 161 billion in 2023 and is expected to reach USD 297.18 billion by 2032, growing at a CAGR of...
-
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival (PFS) of 22.1 months across all doses tested Emerging...
-
-- Bezuclastinib achieves clear clinical benefit across all symptom domains including significant improvements on 11 individual symptoms plus the most severe symptom at baseline -- ...